AI-enabled drug repurposing in Alzheimer’s disease: from computational nomination to pharmacological proof
Artificial intelligence (AI) has expanded the scale and speed of drug repurposing in Alzheimer’s disease (AD). Transcriptomic signature matching, network-based systems pharmacology, real-world data pharmacoepidemiology and multi-omics machine learning have generated hundreds of candidate drugs, while repurposed agents...